These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10625883)

  • 1. The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Braz J Med Biol Res; 2000 Jan; 33(1):119-25. PubMed ID: 10625883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic clearance of tissue-type plasminogen activator and plasma kallikrein in experimental liver fibrosis.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Liver Int; 2003 Dec; 23(6):476-83. PubMed ID: 14986822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of a galectin-dependent mechanism in the hepatic clearance of tissue-type plasminogen activator and plasma kallikrein.
    Nagaoka MR; Strital E; Kouyoumdjian M; Borges DR
    Thromb Res; 2002 Nov; 108(4):257-62. PubMed ID: 12617990
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
    van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
    Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and degradation of tissue plasminogen activator in rat liver.
    Einarsson M; Smedsrød B; Pertoft H
    Thromb Haemost; 1988 Jun; 59(3):474-9. PubMed ID: 3142083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma-kallikrein clearance by the liver of acetaminophen-intoxicated rats.
    de Toledo CF; Borges DR
    Life Sci; 1993; 52(17):1451-9. PubMed ID: 8464345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma kallikrein and thrombin are cleared through unrelated hepatic pathways.
    Loureiro-Silva MR; Kouyoumdjian M; Borges DR
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):551-4. PubMed ID: 8218851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clearance rate of plasma kallikrein by the liver increases during the acute-phase response to inflammation.
    Martins B; Kouyoumdjian M; Limaos EA; Borges DR
    Agents Actions; 1992 Sep; 37(1-2):111-3. PubMed ID: 1456171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
    Warshawsky I; Bu G; Schwartz AL
    J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma kallikrein clearance by the liver: a review.
    Borges DR; Kouyoumdjian M
    Braz J Med Biol Res; 1994 Aug; 27(8):2033-41. PubMed ID: 7538375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
    Narita M; Bu G; Herz J; Schwartz AL
    J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic clearance of tissue-type plasminogen activator in rats.
    Emeis JJ; van den Hoogen CM; Jense D
    Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time- and dose-related regional fluxes of tissue-type plasminogen activator in anesthetized endotoxemic pigs.
    Nyberg A; Jakob SM; Seeman-Lodding H; Porta F; Bracht H; Bischofberger H; Jern C; Takala J; Aneman A
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):57-64. PubMed ID: 17999715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma kallikrein clearance by the liver of chronic carbon tetrachloride-treated rats.
    Toledo CF; Kouyoumdjian M; Lanzoni VP; Borges DR
    J Gastroenterol Hepatol; 1995; 10(2):165-8. PubMed ID: 7787162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver.
    Tanswell P; Heinzel G; Greischel A; Krause J
    J Pharmacol Exp Ther; 1990 Oct; 255(1):318-24. PubMed ID: 2120422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma kallikrein clearance by the liver in experimental cirrhosis].
    de Toledo CF; Loureiro-Silva MR; Molina HM; Lanzoni VP; Kouyoumdjian M; Borges DR
    Rev Assoc Med Bras (1992); 1995; 41(6):367-72. PubMed ID: 8733244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turnover of tissue plasminogen activator in normal and hepatectomized rabbits.
    Nilsson S; Einarsson M; Ekvärn S; Häggroth L; Mattsson C
    Thromb Res; 1985 Aug; 39(4):511-21. PubMed ID: 3931294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of the alpha 2 macroglobulin-trypsin complex and uptake of trypsin by perfused liver.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Braz J Med Biol Res; 1996 Jun; 29(6):797-803. PubMed ID: 9070393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.
    Krause J; Seydel W; Heinzel G; Tanswell P
    Biochem J; 1990 May; 267(3):647-52. PubMed ID: 2160232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction.
    Modi NB; Eppler S; Breed J; Cannon CP; Braunwald E; Love TW
    Thromb Haemost; 1998 Jan; 79(1):134-9. PubMed ID: 9459338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.